scispace - formally typeset
S

Stephen V. Faraone

Researcher at State University of New York Upstate Medical University

Publications -  1470
Citations -  155368

Stephen V. Faraone is an academic researcher from State University of New York Upstate Medical University. The author has contributed to research in topics: Attention deficit hyperactivity disorder & Bipolar disorder. The author has an hindex of 188, co-authored 1427 publications receiving 140298 citations. Previous affiliations of Stephen V. Faraone include University of Bergen & National Institute for Health Research.

Papers
More filters
Journal ArticleDOI

Stimulants and Attention-Deficit/Hyperactivity Disorder—Reply

TL;DR: The Contempo Update on attention-deficit/ hyperactivity disorder (ADHD) by Dr Wilens and colleagues presented pharmacologic treatment options, but in discussing the use of stimulant medications, the authors did not address risks of addiction, tolerance, or habituation.
Journal ArticleDOI

Neuroanatomic Predictors to Prodromal Psychosis in Velocardiofacial Syndrome (22q11.2 Deletion Syndrome): A Longitudinal Study

TL;DR: Findings are in line with studies of non-VCFS individuals at risk for schizophrenia and suggest that early decrements in temporal lobe gray matter may be predictive of increased risk of prodromal psychotic symptoms in youth with VCFS.
Journal ArticleDOI

Psychopathology, personality traits and social development of young first-degree relatives of patients with schizophrenia

TL;DR: In this article, the authors identify aspects of personality, psychopathology and social development that differentiate high-risk and control individuals, and find that higher risk individuals have more physical anhedonia, less positive involvement with peers and more problems with peers, siblings and opposite gender.
Journal ArticleDOI

Attention deficit and hyperactivity disorder scores are elevated and respond to N-acetylcysteine treatment in patients with systemic lupus erythematosus.

TL;DR: In patients with SLE, elevated ASRS scores reveal previously unrecognized and clinically significant symptoms of ADHD that respond to N-acetylcysteine treatment.